This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Intensive Care Unit Acquired Weakness
+1

Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

Sponsored by Assistance Publique - Hôpitaux de Paris

About this trial

Last updated 6 months ago

Study ID

APHP220794

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started a year ago

What is this trial about?

Over-resuscitation including fluid overload has been associated with increased morbidity (prolonged duration of organ failure) and mortality in septic shock. "One-size-fits-all" resuscitation strategies may increase septic shock mortality. However, clinical studies on individualized resuscitation are lacking. Hemodynamic phenotyping may allow to individualize septic shock resuscitation. The ANDROMEDA-SHOCK trial found that a simple clinical and bedside CRT-targeted resuscitation reduces organ dysfunction and 28-day mortality in septic shock. The current study will examine the hypothesis that a CRT-targeted resuscitation based on hemodynamic phenotyping considering within an decision tree usual bedside clinical parameters such as pulse pressure, diastolic blood pressure, fluid responsiveness and cardiac performance can further decrease mortality in septic shock as compared to usual care.

What are the participation requirements?

Yes

Inclusion Criteria

- Consecutive adult patients (≥ 18 years)

- Patients with septic shock according to Sepsis-3 consensus conference. In short, septic shock is defined as suspected or confirmed infection, plus hyperlactatemia and NE requirements due to persistent hypotension, after a fluid load of at least 1000mL in 1h

- Patient and/or relative informed and having signed the information and consent form for participation in the study

No

Exclusion Criteria

- More than 4 hours since septic shock diagnosis,

- Anticipated surgery or acute hemodialysis procedure to start during the 6h intervention period

- Active bleeding,

- Do not resuscitate status,

- Child B-C Cirrhosis

- Underlying disease process with a life expectancy < 90 days and/or the attending clinician deems aggressive resuscitation unsuitable

- Refractory shock (high risk of death within 24h)

- Pregnancy

- Concomitant severe acute respiratory distress syndrome

- Patients in whom CRT cannot be accurately assessed

- Non-affiliation to a social security scheme or to another social protection scheme

- Patient on AME (state medical aid) (unless exemption from affiliation

- Patient under legal protection (guardianship, curatorship)

- Participation in another interventional study involving human participants or being in the exclusion period at the end of a previous study involving human participants, if applicable

- Inability, according to the investigator, to understand the study (non-French-speaking patient, cognitive disorders)

Locations

Location

Status

Recruiting